Regulation of low-density lipoprotein receptor expression in triple negative breast cancer by EGFR-MAPK signaling
Abstract Expression of the low-density lipoprotein receptor (LDLR) has been shown to play a critical role in hypercholesterolemia-associated breast cancer growth and is associated with shorter recurrence-free survival in human breast cancer studies. We sought to identify how circulating LDL choleste...
Guardado en:
Autores principales: | Tiffany Scully, Nathan Kase, Emily J. Gallagher, Derek LeRoith |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4637f21548d947e5b1af8ade15841430 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies
por: Nina Radosevic-Robin, et al.
Publicado: (2021) -
Peptide density targets and impedes triple negative breast cancer metastasis
por: Daxing Liu, et al.
Publicado: (2018) -
Deguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells.
por: Rajeshwari Mehta, et al.
Publicado: (2013) -
Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner J, et al.
Publicado: (2015) -
A triple negative breast cancer: what it is not!
por: Katakkar SB
Publicado: (2012)